4//SEC Filing
Jandrich Steven 4
Accession 0001104659-23-055529
CIK 0001609550other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:35 PM ET
Size
14.9 KB
Accession
0001104659-23-055529
Insider Transaction Report
Form 4
Jandrich Steven
Chief Comp Off & VP, Human Res
Transactions
- Sale
Common Stock
2023-04-25$270.24/sh−5,499$1,486,050→ 6,872 total - Exercise/Conversion
Common Stock
2023-04-25$42.15/sh+8,000$337,200→ 12,371 total - Sale
Common Stock
2023-04-25$271.20/sh−401$108,751→ 6,471 total - Sale
Common Stock
2023-04-25$273.03/sh−2,100$573,363→ 4,371 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-04-25−8,000→ 5,432 totalExercise: $42.15Exp: 2028-12-18→ Common Stock (8,000 underlying)
Holdings
- 478(indirect: By daughter)
Common Stock
- 478(indirect: By son)
Common Stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2022 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.78, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.08 to $271.49, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.00 to $273.06, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Documents
Issuer
Inspire Medical Systems, Inc.
CIK 0001609550
Entity typeother
Related Parties
1- filerCIK 0001737203
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:35 PM ET
- Size
- 14.9 KB